BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | Genetics in Medicine
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP
Researchers develop comprehensive new way to predict breast cancer risk | CRUK CC
Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry | Breast Cancer Research
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman | SpringerLink
BOADICEA Risk Model - FamGenix
Breast cancer risk evaluation for the primary care physician | Cleveland Clinic Journal of Medicine
Decision aid for breast cancer risk stratification. The percentages... | Download Scientific Diagram
Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort | BMJ Open
The BOADICEA Project – translational research in practice - ppt download
Valoración de riesgo y medidas de prevención en cáncer hereditario
Breast Cancer Risk Models Made Easy To Use
Genetics of Breast and Gynecologic Cancers (PDQ®)–Health Professional Version - NCI
Applicability and ease of use of risk assessment models. | Download Table
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial
BOADICEA Risk Model - FamGenix
Breast Cancer Risk Assessment: Calculating Lifetime Risk Using the Tyrer-Cuzick Model - ScienceDirect
Welcome to CanRisk
Cancer Risk Assessment | PhenoTips
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface | British Journal of Cancer
Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations | British Journal of Cancer
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
